Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study

ABSTRACT:

SUBMITTER: Icli M 

PROVIDER: S-EPMC12942511 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature